IS2904B - Aðferð við að framleiða stofna af Vibrio cholerae sem skortir thy A, slíkir stofnar og notkun þeirra - Google Patents

Aðferð við að framleiða stofna af Vibrio cholerae sem skortir thy A, slíkir stofnar og notkun þeirra

Info

Publication number
IS2904B
IS2904B IS5724A IS5724A IS2904B IS 2904 B IS2904 B IS 2904B IS 5724 A IS5724 A IS 5724A IS 5724 A IS5724 A IS 5724A IS 2904 B IS2904 B IS 2904B
Authority
IS
Iceland
Prior art keywords
thy
strain
vibrio cholerae
sup
strains
Prior art date
Application number
IS5724A
Other languages
English (en)
Other versions
IS5724A (is
Inventor
Nils Carlin
Michael R Lebens
Original Assignee
Crucell Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crucell Sweden Ab filed Critical Crucell Sweden Ab
Publication of IS5724A publication Critical patent/IS5724A/is
Publication of IS2904B publication Critical patent/IS2904B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
IS5724A 1998-05-26 2000-11-23 Aðferð við að framleiða stofna af Vibrio cholerae sem skortir thy A, slíkir stofnar og notkun þeirra IS2904B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801852A SE9801852D0 (sv) 1998-05-26 1998-05-26 Method of producing thy A-strains of Vibro cholerae, suck strains and their use
PCT/EP1999/003509 WO1999061634A1 (en) 1998-05-26 1999-05-21 Method of producing thy a-strains of vibrio cholerae, such strains and their use

Publications (2)

Publication Number Publication Date
IS5724A IS5724A (is) 2000-11-23
IS2904B true IS2904B (is) 2014-10-15

Family

ID=20411459

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5724A IS2904B (is) 1998-05-26 2000-11-23 Aðferð við að framleiða stofna af Vibrio cholerae sem skortir thy A, slíkir stofnar og notkun þeirra

Country Status (17)

Country Link
US (1) US7261899B1 (is)
EP (1) EP1080211B1 (is)
AT (1) ATE474055T1 (is)
AU (1) AU4499999A (is)
BR (1) BR9910703B1 (is)
CA (1) CA2329255C (is)
CZ (1) CZ301662B6 (is)
DE (1) DE69942579D1 (is)
DK (1) DK1080211T3 (is)
EE (1) EE05520B1 (is)
HU (1) HUP0102310A3 (is)
IS (1) IS2904B (is)
NO (1) NO327856B1 (is)
PL (1) PL197450B1 (is)
RU (1) RU2265657C2 (is)
SE (1) SE9801852D0 (is)
WO (1) WO1999061634A1 (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU22661A1 (es) * 1997-12-30 2001-04-27 Cnic Ct Nac Investigaciones Nuevos candidatos vacunales de vibrio cholerae y método de obtención
SE9801852D0 (sv) * 1998-05-26 1998-05-26 Sbl Vaccin Ab Method of producing thy A-strains of Vibro cholerae, suck strains and their use
RU2193598C1 (ru) * 2001-07-26 2002-11-27 Федеральное государственное учреждение Российский научно-исследовательский противочумный институт "Микроб" Штамм бактерий vibrio cholerae km 200 - продуцент холерного токсина и токсин - корегулируемых пилей адгезии
GB0121998D0 (en) 2001-09-11 2001-10-31 Acambis Res Ltd Attenuated bacteria useful in vaccines
RU2236455C1 (ru) * 2003-10-27 2004-09-20 Федеральное государственное учреждение Российский научно-исследовательский противочумный институт "Микроб" Штамм бактерий vibrio cholerae км 168 - основа для конструирования живых вакцин против диарейных заболеваний, вызываемых патогенными штаммами v. cholerae о139
GB0325494D0 (en) * 2003-10-31 2003-12-03 Sbl Vaccin Ab Expression system
JP2010088301A (ja) * 2007-02-01 2010-04-22 Ajinomoto Co Inc L−アミノ酸の製造法
EP3503915B1 (en) * 2016-08-26 2024-02-21 Telesis Bio Inc. Genetically engineered vibrio natriegens

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470729A (en) * 1983-03-04 1995-11-28 University Of Maryland At Baltimore Method of isolating restriction fragment deletions in Vibrio cholerae, and products thereof
US5399494A (en) * 1983-03-04 1995-03-21 The University Of Maryland System Vibrio cholerae strain CVD103Hgr, method of making same, and vaccines derived therefrom
GB2177097A (en) 1985-06-18 1987-01-14 Genencor Inc Stable maintenance of nucleic acid in recombinant cells
EP0251579A3 (en) 1986-06-24 1989-03-22 Enterovax Research Pty. Ltd. Non-antibiotic marker system
US5198343A (en) 1986-08-05 1993-03-30 Transgene, S.A. Method for expressing a heterologous protein in a dapD- mutant of E. coli and the strain obtained
IE892131A1 (en) * 1989-06-30 1991-01-02 Univ Cork Marker genes for genetic manipulation
EP0692031B1 (en) * 1993-02-22 2007-04-11 The General Hospital Corporation Heterologous antigens in live cell vaccine strains
US5434065A (en) * 1993-05-06 1995-07-18 President And Fellows Of Harvard College In vivo selection of microbial virulence genes
DE69533964T2 (de) * 1994-10-24 2006-03-30 The Texas A & M University System, College Station Orale immunisierung durch verwendung von transgenen pflanzen
US6251866B1 (en) * 1997-08-05 2001-06-26 Watson Laboratories, Inc. Conjugates targeted to the interleukin-2 receptor
CU22661A1 (es) * 1997-12-30 2001-04-27 Cnic Ct Nac Investigaciones Nuevos candidatos vacunales de vibrio cholerae y método de obtención
SE9801852D0 (sv) * 1998-05-26 1998-05-26 Sbl Vaccin Ab Method of producing thy A-strains of Vibro cholerae, suck strains and their use

Also Published As

Publication number Publication date
US7261899B1 (en) 2007-08-28
CA2329255A1 (en) 1999-12-02
ATE474055T1 (de) 2010-07-15
HUP0102310A2 (hu) 2001-10-28
EP1080211A1 (en) 2001-03-07
HUP0102310A3 (en) 2003-10-28
HK1037206A1 (en) 2002-02-01
WO1999061634A1 (en) 1999-12-02
BR9910703B1 (pt) 2014-10-29
SE9801852D0 (sv) 1998-05-26
DE69942579D1 (de) 2010-08-26
PL344483A1 (en) 2001-11-05
EP1080211B1 (en) 2010-07-14
IS5724A (is) 2000-11-23
WO1999061634A9 (en) 2001-12-13
RU2265657C2 (ru) 2005-12-10
NO20005950D0 (no) 2000-11-24
NO20005950L (no) 2001-01-25
AU4499999A (en) 1999-12-13
NO327856B1 (no) 2009-10-05
EE200000686A (et) 2002-04-15
BR9910703A (pt) 2001-01-30
CZ301662B6 (cs) 2010-05-19
DK1080211T3 (da) 2010-10-18
PL197450B1 (pl) 2008-03-31
CA2329255C (en) 2009-03-10
EE05520B1 (et) 2012-02-15
CZ20004354A3 (en) 2001-05-16

Similar Documents

Publication Publication Date Title
Kotewicz et al. Cloning and overexpression of Moloney murine leukemia virus reverse transcriptase in Escherichia coli
Franz et al. Minos, a new transposable element from Drosophila hydei, is a member of the Tc1-like family of transposons
JPH0724582B2 (ja) トリプトファン・プロモーター―オペレーターを用いる細菌によるポリペプチドの発現用ベクター
ATE77104T1 (de) Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute.
JP2005287333A5 (is)
IS5724A (is) Aðferð við að framleiða thy A stofna af Vibrio cholerae, slíkir stofnar og notkun þeirra
US5093251A (en) Cassette method of gene synthesis
WO1991018101A1 (en) Process for producing protein
WO2001038484A3 (en) Moss genes from physcomitrella patens coding proteins involved in the synthesis of polyunsaturated fatty acids and lipids
WO2001044276A3 (en) Moss genes from physcomitrella patens encoding proteins involved in the synthesis of tocopherols carotenoids and aromatic amino acids
ATE480624T1 (de) Yapsin-mangelmutantenstamm von hansenula polymorpha sowie verfahren zur herstellung rekombinanter proteine damit
EP0114695B1 (en) Dna coding for a signal amino acid sequence and vectors containing the same
RU2000132731A (ru) Способ получения thy a-штаммов vibro cholerae, такие штаммы и их применение
JP2005508184A5 (is)
RU99128056A (ru) Сосудистый белок-1 адгезии, обладающий аминоксидазной активностью
EP0672150A1 (fr) Levures kluyveromyces modifiees, preparation et utilisation
KR100538990B1 (ko) 티벡터와 발현벡터로의 기능을 동시에 가지는 플라스미드및 이를 이용한 목적유전자의 발현
EP0179786A1 (en) EXPRESSION VECTORS WITH HIGH COPIES.
KR100428998B1 (ko) 모체 단백질과는 크기와 서열이 다른 단백질의 변이집단을생산하는 방법
DK1633873T3 (da) Bakterier med forøgede niveauer af proteinsekretion, nukleotidsekvenser kodende for et SecA-protein med forøgede niveauer af proteinsekretion og fremgangsmåde til fremstilling af proteiner
EP0135347A1 (en) Human renin and cDNA encoding therefor
EP0494149A1 (en) Modified proteases and their use in foodstuffs
Revel et al. Production of interferon
JPH08228787A (ja) 牛成長ホルモンの大量生産方法
Monahan A Review of the Basic Elements of Recombinant DNA Research